Detection and treatment of intravascular thrombi with magnetofluorescent nanoparticles

S. Sibel Erdem, Irina Yurievna Sazonova, Tetsuya Hara, Farouc A. Jaffer, Jason R. McCarthy

Research output: Chapter in Book/Report/Conference proceedingChapter

8 Citations (Scopus)

Abstract

Thrombosis, the formation of a clot within a blood vessel, underlies a number of life-threatening cardiovascular disorders such as heart attack, ischemic stroke, pulmonary embolism, and deep vein thrombosis. These conditions affect the lives of millions of people worldwide and result in significant morbidity and mortality. It is thus crucial to develop novel methodologies to enhance the detection and treatment of these disorders. Thrombolysis, or the dissolution of blood clots, relies upon the administration of exogenous plasminogen activators (PAs) that lyse fibrin. Yet, there are several drawbacks to the use of current PAs, including significant risks of uncontrolled bleeding and suboptimal efficacy and pharmacokinetics. Nanomaterials are well positioned to address these priority issues in thrombolysis, via the alteration of PA pharmacokinetics and biodistribution. Additionally, due to the multifunctional nature of nanoparticles, these thrombolytics may be targeted to the site of occlusion, effectively concentrating the drug where it is most needed. Herein, we describe the methodology associated with the synthesis of a novel thrombus-targeted fibrinolytic nanoagent. At each step of the synthesis, we analyze the nanomaterials, including their physical properties and their ability to bind to thrombosis targets of interest. The effect of the conjugation of tPA to the nanoparticle surface on the amidolytic and fibrinolytic activities of nanoagents is also investigated. Lastly, the in vivo binding of the targeted thrombolytic to intravascular thrombi is examined.

Original languageEnglish (US)
Title of host publicationMethods in Enzymology
PublisherAcademic Press Inc.
Pages191-209
Number of pages19
DOIs
StatePublished - Jan 1 2012

Publication series

NameMethods in Enzymology
Volume508
ISSN (Print)0076-6879
ISSN (Electronic)1557-7988

Fingerprint

Plasminogen Activators
Nanoparticles
Thrombosis
Pharmacokinetics
Nanostructured materials
Nanostructures
Blood vessels
Fibrin
Dissolution
Blood
Physical properties
Pulmonary Embolism
Venous Thrombosis
Blood Vessels
Pharmaceutical Preparations
Stroke
Myocardial Infarction
Hemorrhage
Morbidity
Mortality

Keywords

  • Iron oxide
  • Nanomedicine
  • Peptide-targeted
  • Plasminogen activator
  • Thrombolysis

ASJC Scopus subject areas

  • Biochemistry
  • Molecular Biology

Cite this

Erdem, S. S., Sazonova, I. Y., Hara, T., Jaffer, F. A., & McCarthy, J. R. (2012). Detection and treatment of intravascular thrombi with magnetofluorescent nanoparticles. In Methods in Enzymology (pp. 191-209). (Methods in Enzymology; Vol. 508). Academic Press Inc.. https://doi.org/10.1016/B978-0-12-391860-4.00010-0

Detection and treatment of intravascular thrombi with magnetofluorescent nanoparticles. / Erdem, S. Sibel; Sazonova, Irina Yurievna; Hara, Tetsuya; Jaffer, Farouc A.; McCarthy, Jason R.

Methods in Enzymology. Academic Press Inc., 2012. p. 191-209 (Methods in Enzymology; Vol. 508).

Research output: Chapter in Book/Report/Conference proceedingChapter

Erdem, SS, Sazonova, IY, Hara, T, Jaffer, FA & McCarthy, JR 2012, Detection and treatment of intravascular thrombi with magnetofluorescent nanoparticles. in Methods in Enzymology. Methods in Enzymology, vol. 508, Academic Press Inc., pp. 191-209. https://doi.org/10.1016/B978-0-12-391860-4.00010-0
Erdem SS, Sazonova IY, Hara T, Jaffer FA, McCarthy JR. Detection and treatment of intravascular thrombi with magnetofluorescent nanoparticles. In Methods in Enzymology. Academic Press Inc. 2012. p. 191-209. (Methods in Enzymology). https://doi.org/10.1016/B978-0-12-391860-4.00010-0
Erdem, S. Sibel ; Sazonova, Irina Yurievna ; Hara, Tetsuya ; Jaffer, Farouc A. ; McCarthy, Jason R. / Detection and treatment of intravascular thrombi with magnetofluorescent nanoparticles. Methods in Enzymology. Academic Press Inc., 2012. pp. 191-209 (Methods in Enzymology).
@inbook{1015374db30e4ef0bc70b565bfe56025,
title = "Detection and treatment of intravascular thrombi with magnetofluorescent nanoparticles",
abstract = "Thrombosis, the formation of a clot within a blood vessel, underlies a number of life-threatening cardiovascular disorders such as heart attack, ischemic stroke, pulmonary embolism, and deep vein thrombosis. These conditions affect the lives of millions of people worldwide and result in significant morbidity and mortality. It is thus crucial to develop novel methodologies to enhance the detection and treatment of these disorders. Thrombolysis, or the dissolution of blood clots, relies upon the administration of exogenous plasminogen activators (PAs) that lyse fibrin. Yet, there are several drawbacks to the use of current PAs, including significant risks of uncontrolled bleeding and suboptimal efficacy and pharmacokinetics. Nanomaterials are well positioned to address these priority issues in thrombolysis, via the alteration of PA pharmacokinetics and biodistribution. Additionally, due to the multifunctional nature of nanoparticles, these thrombolytics may be targeted to the site of occlusion, effectively concentrating the drug where it is most needed. Herein, we describe the methodology associated with the synthesis of a novel thrombus-targeted fibrinolytic nanoagent. At each step of the synthesis, we analyze the nanomaterials, including their physical properties and their ability to bind to thrombosis targets of interest. The effect of the conjugation of tPA to the nanoparticle surface on the amidolytic and fibrinolytic activities of nanoagents is also investigated. Lastly, the in vivo binding of the targeted thrombolytic to intravascular thrombi is examined.",
keywords = "Iron oxide, Nanomedicine, Peptide-targeted, Plasminogen activator, Thrombolysis",
author = "Erdem, {S. Sibel} and Sazonova, {Irina Yurievna} and Tetsuya Hara and Jaffer, {Farouc A.} and McCarthy, {Jason R.}",
year = "2012",
month = "1",
day = "1",
doi = "10.1016/B978-0-12-391860-4.00010-0",
language = "English (US)",
series = "Methods in Enzymology",
publisher = "Academic Press Inc.",
pages = "191--209",
booktitle = "Methods in Enzymology",
address = "United States",

}

TY - CHAP

T1 - Detection and treatment of intravascular thrombi with magnetofluorescent nanoparticles

AU - Erdem, S. Sibel

AU - Sazonova, Irina Yurievna

AU - Hara, Tetsuya

AU - Jaffer, Farouc A.

AU - McCarthy, Jason R.

PY - 2012/1/1

Y1 - 2012/1/1

N2 - Thrombosis, the formation of a clot within a blood vessel, underlies a number of life-threatening cardiovascular disorders such as heart attack, ischemic stroke, pulmonary embolism, and deep vein thrombosis. These conditions affect the lives of millions of people worldwide and result in significant morbidity and mortality. It is thus crucial to develop novel methodologies to enhance the detection and treatment of these disorders. Thrombolysis, or the dissolution of blood clots, relies upon the administration of exogenous plasminogen activators (PAs) that lyse fibrin. Yet, there are several drawbacks to the use of current PAs, including significant risks of uncontrolled bleeding and suboptimal efficacy and pharmacokinetics. Nanomaterials are well positioned to address these priority issues in thrombolysis, via the alteration of PA pharmacokinetics and biodistribution. Additionally, due to the multifunctional nature of nanoparticles, these thrombolytics may be targeted to the site of occlusion, effectively concentrating the drug where it is most needed. Herein, we describe the methodology associated with the synthesis of a novel thrombus-targeted fibrinolytic nanoagent. At each step of the synthesis, we analyze the nanomaterials, including their physical properties and their ability to bind to thrombosis targets of interest. The effect of the conjugation of tPA to the nanoparticle surface on the amidolytic and fibrinolytic activities of nanoagents is also investigated. Lastly, the in vivo binding of the targeted thrombolytic to intravascular thrombi is examined.

AB - Thrombosis, the formation of a clot within a blood vessel, underlies a number of life-threatening cardiovascular disorders such as heart attack, ischemic stroke, pulmonary embolism, and deep vein thrombosis. These conditions affect the lives of millions of people worldwide and result in significant morbidity and mortality. It is thus crucial to develop novel methodologies to enhance the detection and treatment of these disorders. Thrombolysis, or the dissolution of blood clots, relies upon the administration of exogenous plasminogen activators (PAs) that lyse fibrin. Yet, there are several drawbacks to the use of current PAs, including significant risks of uncontrolled bleeding and suboptimal efficacy and pharmacokinetics. Nanomaterials are well positioned to address these priority issues in thrombolysis, via the alteration of PA pharmacokinetics and biodistribution. Additionally, due to the multifunctional nature of nanoparticles, these thrombolytics may be targeted to the site of occlusion, effectively concentrating the drug where it is most needed. Herein, we describe the methodology associated with the synthesis of a novel thrombus-targeted fibrinolytic nanoagent. At each step of the synthesis, we analyze the nanomaterials, including their physical properties and their ability to bind to thrombosis targets of interest. The effect of the conjugation of tPA to the nanoparticle surface on the amidolytic and fibrinolytic activities of nanoagents is also investigated. Lastly, the in vivo binding of the targeted thrombolytic to intravascular thrombi is examined.

KW - Iron oxide

KW - Nanomedicine

KW - Peptide-targeted

KW - Plasminogen activator

KW - Thrombolysis

UR - http://www.scopus.com/inward/record.url?scp=84859063275&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84859063275&partnerID=8YFLogxK

U2 - 10.1016/B978-0-12-391860-4.00010-0

DO - 10.1016/B978-0-12-391860-4.00010-0

M3 - Chapter

AN - SCOPUS:84859063275

T3 - Methods in Enzymology

SP - 191

EP - 209

BT - Methods in Enzymology

PB - Academic Press Inc.

ER -